{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:32:18Z","timestamp":1793061138637,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:00:00Z","timestamp":1793059200000},"content-version":"vor","delay-in-days":99,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai Minhang District Natural Science Research Project","award":["2024MHZ078"],"award-info":[{"award-number":["2024MHZ078"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-026-00888-8","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T08:24:05Z","timestamp":1784535845000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigation and characteristics of 115 cases with unexpected antibodies for improving transfusion strategies: a retrospective study"],"prefix":"10.1186","volume":"27","author":[{"given":"Caili","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"888_CR1","unstructured":"National Health Commission of the People\u2019s Republic of China. Terminology of Transfusion Medicine (WS\/T 203\u20132020). 2020. Available at: http:\/\/www.nhc.gov.cn\/wjw\/s9493\/202005\/805e3744d326435fab3e05bdaf3001d8\/files\/1739782071145_99098.pdf"},{"issue":"5","key":"888_CR2","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/bjh.15182","volume":"181","author":"CA Tormey","year":"2018","unstructured":"Tormey CA, Selleck R, Erickson Y, et al. Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database. Br J Haematol. 2018;181(5):672\u201381.","journal-title":"Br J Haematol"},{"issue":"1","key":"888_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.12982\/JAMS.2026.016]","volume":"59","author":"U Lao-on","year":"2026","unstructured":"Lao-on U, Lao-on K. A review on the prevalence of unexpected alloantibodies in Thai patients across Thailand. J Assoc Med Sci. 2026;59(1):129\u201336. https:\/\/doi.org\/10.12982\/JAMS.2026.016].","journal-title":"J Assoc Med Sci"},{"key":"888_CR4","doi-asserted-by":"publisher","unstructured":"Zhang HD. Establishment of a predictive model for transfusion efficacy in critically ill patients. Shijiazhuang: Hebei Medical University; 2024. https:\/\/doi.org\/10.27111\/d.cnki.ghyku.2024.001301","DOI":"10.27111\/d.cnki.ghyku.2024.001301"},{"issue":"4","key":"888_CR5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.13201\/j.issn.1004-2806.2023.04.002","volume":"36","author":"N Li","year":"2023","unstructured":"Li N, Li GN, Gan L, et al. Analysis of unexpected antibody screening results in pre-transfusion patients at a single center. J Clin Hematol. 2023;36(4):230\u20134. https:\/\/doi.org\/10.13201\/j.issn.1004-2806.2023.04.002.","journal-title":"J Clin Hematol"},{"issue":"1","key":"888_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.13303\/j.cjbt.issn.1004-549x.2025.01.009","volume":"38","author":"X Xiao","year":"2025","unstructured":"Xiao X, Chen L, Zhao ZY, et al. Clinical significance of establishing a database for red blood cell alloantibody detection. Chin J Blood Transfus. 2025;38(1):54\u201360. https:\/\/doi.org\/10.13303\/j.cjbt.issn.1004-549x.2025.01.009.","journal-title":"Chin J Blood Transfus"},{"issue":"6","key":"888_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.13201\/j.issn.1004-2806.2024.06.007","volume":"37","author":"XR Zhao","year":"2024","unstructured":"Zhao XR, Jiang XC. Analysis of transfusion strategies for patients with positive irregular antibody screening. J Clin Hematol. 2024;37(6):405\u20138. https:\/\/doi.org\/10.13201\/j.issn.1004-2806.2024.06.007.","journal-title":"J Clin Hematol"},{"issue":"21","key":"888_CR8","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.3969\/j.issn.1003-6350.2024.21.018","volume":"35","author":"XY Gou","year":"2024","unstructured":"Gou XY, Fu WD, Yang LF. Specificity identification and disease distribution of unexpected antibodies in red blood cell in 55,056 hospitalized patients. Hainan Med J. 2024;35(21):3126\u201330. https:\/\/doi.org\/10.3969\/j.issn.1003-6350.2024.21.018.","journal-title":"Hainan Med J"},{"issue":"2","key":"888_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.13201\/j.issn.1004-2806.2026.02.010","volume":"39","author":"Q Long","year":"2026","unstructured":"Long Q, Zhao S, Zhao QQ, et al. Clinical distribution and influencing factors of unexpected antibodies. J Clin Hematol. 2026;39(2):155\u20138. https:\/\/doi.org\/10.13201\/j.issn.1004-2806.2026.02.010.","journal-title":"J Clin Hematol"},{"issue":"6","key":"888_CR10","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.19746\/j.cnki.issn1009-2137.2024.06.035","volume":"32","author":"J Li","year":"2024","unstructured":"Li J, Xu X, Li CF, et al. Identification and analysis of unexpected antibodies in hospitalized patients awaiting transfusion. J Exp Hematol. 2024;32(6):1865\u20138. https:\/\/doi.org\/10.19746\/j.cnki.issn1009-2137.2024.06.035.","journal-title":"J Exp Hematol"},{"issue":"4","key":"888_CR11","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3969\/j.issn.1671-2587.2025.04.005","volume":"27","author":"HY Xu","year":"2025","unstructured":"Xu HY, Zhang YN, Liang Y, et al. Distribution and retrospective analysis of ABO blood types, Rh phenotypes, and unexpected antibodies in 7,567 hospitalized patients with malignant tumors. Clin Transfus LabMed. 2025;27(4):462\u2013doi469. https:\/\/doi.org\/10.3969\/j.issn.1671-2587.2025.04.005.","journal-title":"Clin Transfus LabMed"},{"issue":"3","key":"888_CR12","doi-asserted-by":"publisher","first-page":"961","DOI":"10.19746\/j.cnki.issn1009-2137.2020.03.040","volume":"28","author":"RQ Hou","year":"2020","unstructured":"Hou RQ, Yang HY, Cui YP, et al. Analysis of irregular antibody identification results and their clinical significance. J Exp Hematol. 2020;28(3):961\u20136. https:\/\/doi.org\/10.19746\/j.cnki.issn1009-2137.2020.03.040.","journal-title":"J Exp Hematol"},{"key":"888_CR13","doi-asserted-by":"publisher","first-page":"6629060","DOI":"10.1155\/2021\/6629060","volume":"2021","author":"SB Abegaz","year":"2021","unstructured":"Abegaz SB. Human ABO blood groups and their associations with different diseases. Biomed Res Int. 2021;2021:6629060. https:\/\/doi.org\/10.1155\/2021\/6629060.","journal-title":"Biomed Res Int"},{"issue":"6","key":"888_CR14","doi-asserted-by":"publisher","first-page":"7498","DOI":"10.1002\/cam4.5476","volume":"12","author":"C Wang","year":"2023","unstructured":"Wang C, Zhou J, Wang L, et al. ABO blood groups and expression in blood group antigens of epithelial ovarian cancer in Chinese women. Cancer Med. 2023;12(6):7498\u2013507. https:\/\/doi.org\/10.1002\/cam4.5476.","journal-title":"Cancer Med"},{"issue":"4","key":"888_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3892\/ol.2022.13460","volume":"24","author":"H Yang","year":"2022","unstructured":"Yang H, Tan Z, Zhang Y, Sun J, Huang P. ABO blood classification and the risk of lung cancer: A meta-analysis and trial sequential analysis. Oncol Lett. 2022;24(4):340. https:\/\/doi.org\/10.3892\/ol.2022.13460.","journal-title":"Oncol Lett"},{"issue":"2","key":"888_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3969\/j.issn.1002-266X.2025.02.031","volume":"65","author":"X Gao","year":"2025","unstructured":"Gao X, Jiao J, Wu W. Research progress on the relationship between ABO blood groups and various malignant tumors. Shandong Med J. 2025;65(2):149\u201354. https:\/\/doi.org\/10.3969\/j.issn.1002-266X.2025.02.031.","journal-title":"Shandong Med J"},{"issue":"1","key":"888_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.19746\/j.cnki.issn1009-2137.2024.01.037","volume":"32","author":"T Zhang","year":"2024","unstructured":"Zhang T, Yang GL, Zhang HP, et al. Serological characteristics and clinical significance of unexpected antibodies in pregnant women. J Exp Hematol. 2024;32(1):231\u20136. https:\/\/doi.org\/10.19746\/j.cnki.issn1009-2137.2024.01.037.","journal-title":"J Exp Hematol"},{"issue":"12","key":"888_CR18","doi-asserted-by":"publisher","first-page":"874","DOI":"10.13201\/j.issn.1004-2806.2024.12.007","volume":"37","author":"Y Shen","year":"2024","unstructured":"Shen Y, Ni JP, Ke YF. Analysis of prenatal unexpected antibody screening and identification results in pregnant women. J Clin Hematol. 2024;37(12):874\u20139. https:\/\/doi.org\/10.13201\/j.issn.1004-2806.2024.12.007.","journal-title":"J Clin Hematol"},{"issue":"4","key":"888_CR19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3969\/j.issn.1674-1129.2022.04.033","volume":"40","author":"HF Chen","year":"2022","unstructured":"Chen HF, Ye HM. Analysis of irregular antibody screening results in 3341 transfusion recipients. Exp Lab Med. 2022;40(4):511\u20133. https:\/\/doi.org\/10.3969\/j.issn.1674-1129.2022.04.033.","journal-title":"Exp Lab Med"},{"issue":"5","key":"888_CR20","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/vox.70198","volume":"121","author":"IM Taremwa","year":"2026","unstructured":"Taremwa IM, Niyonzima N, Ashaba S, et al. Red blood cell alloantibodies in transfused patients with haematological malignancies at Mbarara Regional Referral Hospital and the Uganda Cancer Institute: Prevalence, specificities and associated factors. Vox Sang. 2026;121(5):614\u201324. https:\/\/doi.org\/10.1111\/vox.70198.","journal-title":"Vox Sang"},{"issue":"1","key":"888_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4103\/0973-6247.106725","volume":"7","author":"CT Wei","year":"2013","unstructured":"Wei CT, Al-Hassan FM, Naim N, Knight A, Joshi SR. Prevalence of Diego blood group antigen and the antibody in three ethnic population groups in Klang valley of Malaysia. Asian J Transfus Sci. 2013;7(1):26\u20138. https:\/\/doi.org\/10.4103\/0973-6247.106725.","journal-title":"Asian J Transfus Sci"},{"issue":"4","key":"888_CR22","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/trf.13430","volume":"56","author":"C Chen","year":"2016","unstructured":"Chen C, Tan J, Wang L, et al. Unexpected red blood cell antibody distributions in Chinese people by a systematic literature review. Transfusion. 2016;56(4):975\u20139. https:\/\/doi.org\/10.1111\/trf.13430.","journal-title":"Transfusion"},{"issue":"2","key":"888_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1182\/blood.V95.2.375","volume":"95","author":"ND Avent","year":"2000","unstructured":"Avent ND, Reid ME. The Rh blood group system: a review. Blood. 2000;95(2):375\u201387. https:\/\/doi.org\/10.1182\/blood.V95.2.375.","journal-title":"Blood"},{"key":"888_CR24","doi-asserted-by":"publisher","unstructured":"Chung Y, Kim JS, Youk H-J et al. Relative immunogenicity of blood group antigens: First report in a Korean population. Transfus Apheres Sci, 62(2), 103585\u2013103585. https:\/\/doi.org\/10.1016\/j.transci.2022.103585","DOI":"10.1016\/j.transci.2022.103585"},{"issue":"2","key":"888_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.13602\/j.cnki.jcls.2023.02.13","volume":"41","author":"CL Wen","year":"2023","unstructured":"Wen CL, Wang SX, Zhang H, et al. Current status of Rh blood group system E, e, C, and c antigen-matched transfusion in China. Chin J Clin Lab Sci. 2023;41(2):139\u201341. https:\/\/doi.org\/10.13602\/j.cnki.jcls.2023.02.13.","journal-title":"Chin J Clin Lab Sci"},{"key":"888_CR26","doi-asserted-by":"publisher","unstructured":"Halawani AJ, Jamalallail SA. prevalences of S and s antigens of the MNS blood group system in the Western Region of Saudi Arabia. Clin Lab. 2026;72(2). https:\/\/doi.org\/10.7754\/Clin.Lab.2025.250681.","DOI":"10.7754\/Clin.Lab.2025.250681"},{"issue":"3","key":"888_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.14164\/j.cnki.cn11-5581\/r.2024.03.042","volume":"18","author":"LQ Li","year":"2024","unstructured":"Li LQ. Effect of anti-M antibody on blood typing and clinical transfusion outcomes. Chin J Mod Drug Appl. 2024;18(3):155\u20138. https:\/\/doi.org\/10.14164\/j.cnki.cn11-5581\/r.2024.03.042.","journal-title":"Chin J Mod Drug Appl"},{"issue":"12","key":"888_CR28","doi-asserted-by":"publisher","first-page":"880","DOI":"10.13201\/j.issn.1004-2806.2024.12.008","volume":"37","author":"LX Tan","year":"2024","unstructured":"Tan LX, Zhao WZ, Wu H, et al. Impact of anti-M antibody on transfusion compatibility testing in patients with cancer and transfusion strategies. J Clin Hematol. 2024;37(12):880\u2013884888. https:\/\/doi.org\/10.13201\/j.issn.1004-2806.2024.12.008.","journal-title":"J Clin Hematol"},{"issue":"4","key":"888_CR29","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1046\/j.1537-2995.1979.19479250186.x","volume":"19","author":"ML Smith","year":"1979","unstructured":"Smith ML, Beck ML. Immunoglobulin structure of human anti-M agglutinins. Transfusion. 1979;19(4):472\u20134. https:\/\/doi.org\/10.1046\/j.1537-2995.1979.19479250186.x.","journal-title":"Transfusion"},{"issue":"6","key":"888_CR30","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3969\/j.issn.1000-8535.2024.06.004","volume":"55","author":"YM Cai","year":"2024","unstructured":"Cai YM. Effect of anti-M antibody on blood typing and clinical transfusion outcomes. Guangzhou Med J. 2024;55(6):596\u2013600632. https:\/\/doi.org\/10.3969\/j.issn.1000-8535.2024.06.004.","journal-title":"Guangzhou Med J"},{"issue":"1","key":"888_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.19522\/j.cnki.1671-5098.2026.01.019","volume":"33","author":"HL Fan","year":"2026","unstructured":"Fan HL. Safe transfusion in a patient with an emergency ectopic pregnancy with anti-M antibodies: A case report. J Pract Med Tech. 2026;33(1):79\u201380. https:\/\/doi.org\/10.19522\/j.cnki.1671-5098.2026.01.019.","journal-title":"J Pract Med Tech"},{"issue":"11","key":"888_CR32","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.3969\/j.issn.1009-5519.2024.11.005","volume":"40","author":"JL Yang","year":"2024","unstructured":"Yang JL, Li H, Zhang L, et al. Distribution of Duffy blood group antibodies and transfusion strategies. Mod Med Health. 2024;40(11):1829\u201318321839. https:\/\/doi.org\/10.3969\/j.issn.1009-5519.2024.11.005.","journal-title":"Mod Med Health"},{"issue":"12","key":"888_CR33","doi-asserted-by":"publisher","first-page":"987","DOI":"10.13201\/j.issn.1004-2806.2025.12.011","volume":"38","author":"J Xie","year":"2025","unstructured":"Xie J, Zhao Q, Su M, et al. Distribution of Duffy blood group phenotypes in Hebei Province and establishment of a rare blood type database. J Clin Hematol. 2025;38(12):987\u201391. https:\/\/doi.org\/10.13201\/j.issn.1004-2806.2025.12.011.","journal-title":"J Clin Hematol"},{"issue":"1","key":"888_CR34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2450\/2017.0119-16","volume":"16","author":"G H\u00f6her","year":"2018","unstructured":"H\u00f6her G, Fiegenbaum M, Almeida S. Molecular basis of the Duffy blood group system. Blood Transfus. 2018;16(1):93\u2013100. https:\/\/doi.org\/10.2450\/2017.0119-16.","journal-title":"Blood Transfus"},{"key":"888_CR35","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/ncomms1265","volume":"2","author":"RE Howes","year":"2011","unstructured":"Howes RE, Patil AP, Piel FB, et al. Global distribution of the Duffy blood group. Nat Commun. 2011;2:266. https:\/\/doi.org\/10.1038\/ncomms1265.","journal-title":"Nat Commun"},{"issue":"3","key":"888_CR36","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/labmed\/lmac104","volume":"54","author":"L Yang","year":"2023","unstructured":"Yang L, Wang H, Jiang Y, Chen J, Zhao H, Feng J. A rare case of hemolytic transfusion reaction in a premature infant caused by passive anti-Jka antibody. Lab Med. 2023;54(3):324\u20136. https:\/\/doi.org\/10.1093\/labmed\/lmac104.","journal-title":"Lab Med"},{"issue":"8","key":"888_CR37","doi-asserted-by":"publisher","first-page":"710","DOI":"10.13423\/j.cnki.cjcmi.009836","volume":"40","author":"L Yang","year":"2024","unstructured":"Yang L, Zhao JY, Yang SM, et al. Identification and analysis of Kidd and Duffy blood group-specific autoantibodies in patient sera. Chin J Cell Mol Immunol. 2024;40(8):710\u20134. https:\/\/doi.org\/10.13423\/j.cnki.cjcmi.009836.","journal-title":"Chin J Cell Mol Immunol"},{"issue":"6","key":"888_CR38","doi-asserted-by":"publisher","first-page":"803","DOI":"10.13303\/j.cjbt.issn.1004-549x.2025.06.009","volume":"38","author":"F Li","year":"2025","unstructured":"Li F, Qiu J, Li HJ, et al. Correlation between Kidd blood group distribution, genotype specificity, and risk of coronary heart disease. Chin J Blood Transfus. 2025;38(6):803\u201310. https:\/\/doi.org\/10.13303\/j.cjbt.issn.1004-549x.2025.06.009.","journal-title":"Chin J Blood Transfus"},{"key":"888_CR39","unstructured":"Serious Hazards of Transfusion (SHOT). Annual SHOT report 2023: hemolytic transfusion reactions (HTR). 2024. Available at: https:\/\/www.shotuk.org"},{"issue":"1","key":"888_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3969\/j.issn.1671-2587.2026.01.011","volume":"28","author":"Y Hu","year":"2026","unstructured":"Hu Y, Bian MH, Bao J. Effect of daratumumab on transfusion compatibility testing and elimination of interference by modified DTT method. Clin Transfus Lab Med. 2026;28(1):70\u20134. https:\/\/doi.org\/10.3969\/j.issn.1671-2587.2026.01.011.","journal-title":"Clin Transfus Lab Med"},{"issue":"8","key":"888_CR41","doi-asserted-by":"publisher","first-page":"568","DOI":"10.13201\/j.issn.1004-2806.2024.08.009","volume":"37","author":"DF Zhang","year":"2024","unstructured":"Zhang DF, Sun SJ, Yu SH. Methods to eliminate interference of CD38 monoclonal antibodies in transfusion compatibility testing: A literature review. J Clin Hematol. 2024;37(8):568\u201370. https:\/\/doi.org\/10.13201\/j.issn.1004-2806.2024.08.009.","journal-title":"J Clin Hematol"},{"issue":"9","key":"888_CR42","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.13303\/j.cjbt.issn.1004-549x.2025.09.017","volume":"38","author":"J Wang","year":"2025","unstructured":"Wang J, Xie YY, Jin S, et al. Diagnosis and detection of immune hemolytic anemia caused by ceftizoxime sodium drug antibody. Chin J Blood Transfus. 2025;38(9):1230\u20135. https:\/\/doi.org\/10.13303\/j.cjbt.issn.1004-549x.2025.09.017.","journal-title":"Chin J Blood Transfus"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-026-00888-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00888-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00888-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:42:17Z","timestamp":1793058137000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-026-00888-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["888"],"URL":"https:\/\/doi.org\/10.1186\/s12865-026-00888-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9562251\/v1","asserted-by":"object"}]},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki.The study protocol was approved by the Ethics Committee of Shanghai Geriatric Medical Center (Approval No. B2026-003B), which waived the requirement for informed consent due to the retrospective nature of the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"101"}}